Skip to main content
Signal8
Malik Fady Ibraham profile photo

Fady Ibraham Malik

CIK: 0001551778

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)61 (50.8%)

Position reduction

Option Exercises (M)47 (39.2%)

Derivative conversions

Awards (A)8 (6.7%)

Compensation grants

Other (G, F, J, C, D, …)4 (3.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CYTOKINETICS INC logo
CYTK

CYTOKINETICS INC

Officer
ROCKET PHARMACEUTICALS, INC. logo
RCKT

ROCKET PHARMACEUTICALS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (120 total)

  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    Nov 3, 2026
    Sale(S)
    Direct
    3.5K shares at avg. $62.93$220K
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    Nov 3, 2026
    Exercise(M)
    Direct
    3.5K shares at avg. $7.80$27K
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    Oct 20, 2026
    Sale(S)
    Direct
    3.5K shares at avg. $64.01$224K
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    Oct 20, 2026
    Exercise(M)
    Direct
    3.5K shares at avg. $7.80$27K
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    Oct 6, 2026
    Exercise(M)
    Direct
    3.5K shares at avg. $7.80$27K
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    Oct 6, 2026
    Sale(S)
    Direct
    3.5K shares at avg. $61.38$215K
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    Sep 22, 2026
    Exercise(M)
    Direct
    3.5K shares at avg. $7.80$27K
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    Sep 22, 2026
    Sale(S)
    Direct
    3.5K shares at avg. $68.29$239K
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    Sep 8, 2026
    Sale(S)
    Direct
    3.5K shares at avg. $75.46$264K
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    Sep 8, 2026
    Exercise(M)
    Direct
    3.5K shares at avg. $7.80$27K
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    Aug 18, 2026
    Sale(S)
    Direct
    3.5K shares at avg. $75.82$265K
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    Aug 18, 2026
    Exercise(M)
    Direct
    3.5K shares at avg. $7.80$27K
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    Jul 21, 2026
    Sale(S)
    Direct
    3.5K shares at avg. $80.59$282K
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    Jul 21, 2026
    Exercise(M)
    Direct
    3.5K shares at avg. $7.80$27K
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    Jul 7, 2026
    Exercise(M)
    Direct
    3.5K shares at avg. $7.80$27K
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    Jul 7, 2026
    Sale(S)
    Direct
    3.5K shares at avg. $86.62$303K
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    Jun 23, 2026
    Sale(S)
    Direct
    3.5K shares at avg. $79.51$278K
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    Jun 23, 2026
    Exercise(M)
    Direct
    3.5K shares at avg. $7.80$27K
  • ROCKET PHARMACEUTICALS, INC. logo
    RCKT

    ROCKET PHARMACEUTICALS, INC.

    Jun 18, 2026
    Award(A)
    Direct
    22.9K shares-
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    Jun 9, 2026
    Sale(S)
    Direct
    3.5K shares at avg. $67.98$238K
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    Jun 9, 2026
    Exercise(M)
    Direct
    3.5K shares at avg. $7.80$27K
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    May 19, 2026
    Sale(S)
    Direct
    3.5K shares at avg. $75.69$265K
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    May 19, 2026
    Exercise(M)
    Direct
    3.5K shares at avg. $7.80$27K
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    May 5, 2026
    Exercise(M)
    Direct
    3.5K shares at avg. $7.80$27K
  • CYTOKINETICS INC logo
    CYTK

    CYTOKINETICS INC

    May 5, 2026
    Sale(S)
    Direct
    3.5K shares at avg. $77.37$271K

1-25 of 120

About Malik Fady Ibraham

Malik Fady Ibraham (SEC CIK 0001551778) files insider reports with the SEC as EVP Research & Development of CYTOKINETICS INC (CYTK) and Director of ROCKET PHARMACEUTICALS, INC. (RCKT).

Signal8 holds 58 ownership filings by Malik Fady Ibraham, all Form 4s, filed between Sep 3, 2024 and Oct 20, 2026. Those filings report 118 transactions, from Sep 3, 2024 to Oct 20, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Malik Fady Ibraham's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Malik Fady Ibraham

  • Nov 3, 2026: Open-market sale of CYTK shares (Form 4, code S).
  • Nov 3, 2026: Option exercise of CYTK shares (Form 4, code M).
  • Oct 20, 2026: Open-market sale of CYTK shares (Form 4, code S).
  • Oct 20, 2026: Option exercise of CYTK shares (Form 4, code M).
  • Oct 6, 2026: Option exercise of CYTK shares (Form 4, code M).

Other insiders filing for CYTOKINETICS INC (CYTK)

How to read Form 4 transaction codes